57 related articles for article (PubMed ID: 7332066)
1. Progression from stage IVS to stage IV neuroblastoma with eventual spontaneous resolution.
Altman AC; Gross S
Am J Pediatr Hematol Oncol; 1981; 3(4):441-4. PubMed ID: 7332066
[No Abstract] [Full Text] [Related]
2. The role of surgery, radio- and chemotherapy in the treatment of neuroblastoma and ganglioneuroblastoma.
Wagner HP; Käser H
Prog Pediatr Surg; 1983; 16():1-6. PubMed ID: 6878720
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of neuronal genes defines subtypes of disseminated neuroblastoma with favorable and unfavorable outcome.
Fischer M; Oberthuer A; Brors B; Kahlert Y; Skowron M; Voth H; Warnat P; Ernestus K; Hero B; Berthold F
Clin Cancer Res; 2006 Sep; 12(17):5118-28. PubMed ID: 16951229
[TBL] [Abstract][Full Text] [Related]
4. Identification of DEIN, a novel gene with high expression levels in stage IVS neuroblastoma.
Voth H; Oberthuer A; Simon T; Kahlert Y; Berthold F; Fischer M
Mol Cancer Res; 2007 Dec; 5(12):1276-84. PubMed ID: 18171985
[TBL] [Abstract][Full Text] [Related]
5. Varicella zoster virus infections in neuroblastoma patients: a 31-year clinical study.
Izbicki T; Mazur J; Izbicka E
Anticancer Res; 2003; 23(3C):3061-8. PubMed ID: 12926162
[TBL] [Abstract][Full Text] [Related]
6. Persistence and possible progression of a pelvic neuroblastoma detected by mass screening during 19 months.
Bernstein ML; Azouz EM; Woods W; Tuchman M; Renaud L; Lemieux B
Am J Pediatr Hematol Oncol; 1994 May; 16(2):164-6. PubMed ID: 8166370
[TBL] [Abstract][Full Text] [Related]
7. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification.
Castle VP; Heidelberger KP; Bromberg J; Ou X; Dole M; Nuñez G
Am J Pathol; 1993 Dec; 143(6):1543-50. PubMed ID: 8256847
[TBL] [Abstract][Full Text] [Related]
8. [Neonatal neuroblastoma and prenatal diagnosis].
Messina M; Di Maggio G; Garzi A; Molinaro F; Amato G; Ferrara F
Minerva Pediatr; 2009 Jun; 61(3):349-54. PubMed ID: 19461577
[TBL] [Abstract][Full Text] [Related]
9. Pattern and outcome of neuroblastoma. A 10 year study.
Kusumakumary P; Ajithkumar TV; Ratheesan K; Chellam VG; Nair MK
Indian Pediatr; 1998 Mar; 35(3):223-9. PubMed ID: 9707875
[TBL] [Abstract][Full Text] [Related]
10. Neuroblastoma--a surgical perspective.
Losty P; Quinn F; Breatnach F; O'Meara A; Fitzgerald RJ
Eur J Surg Oncol; 1993 Feb; 19(1):33-6. PubMed ID: 8436238
[TBL] [Abstract][Full Text] [Related]
11. Neuroblastoma.
Meir HM; Balawi I; Nayel H; Yousef MK; Badawood S; Al-Mobarak M
Saudi Med J; 2001 Aug; 22(8):674-80. PubMed ID: 11573111
[TBL] [Abstract][Full Text] [Related]
12. [Neonatal stage IV and IVs neuroblastoma: surgical treatment with silo and liver reduction].
Sferco A; Defago V; Moyano J; Tramunt B; Berretta A; Romero Manteola E
Cir Pediatr; 2014 Oct; 27(4):189-92. PubMed ID: 26065112
[TBL] [Abstract][Full Text] [Related]
13. ARID3B induces malignant transformation of mouse embryonic fibroblasts and is strongly associated with malignant neuroblastoma.
Kobayashi K; Era T; Takebe A; Jakt LM; Nishikawa S
Cancer Res; 2006 Sep; 66(17):8331-6. PubMed ID: 16951138
[TBL] [Abstract][Full Text] [Related]
14. [Neuroblastoma. Results of protocol N-I-87].
Castel Sánchez V; Badal Iranzo MD; Bezanilla Regato JL; Herrero Díez A; Llombart Bosch A; Ruiz Jiménez JI; Sánchez de Toledo J
An Esp Pediatr; 1993 May; 38(5):471-6. PubMed ID: 8503598
[No Abstract] [Full Text] [Related]
15. Neuroblastoma in the first year of life: clinical and biologic factors influencing outcome.
Grosfeld JL; Rescorla FJ; West KW; Goldman J
Semin Pediatr Surg; 1993 Feb; 2(1):37-46. PubMed ID: 8062021
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients.
Strenger V; Kerbl R; Dornbusch HJ; Ladenstein R; Ambros PF; Ambros IM; Urban C
Pediatr Blood Cancer; 2007 May; 48(5):504-9. PubMed ID: 16732582
[TBL] [Abstract][Full Text] [Related]
17. [Usefulness of determination of concentrations of catecholamines and their metabolites in the urine of children with neuroblastoma for diagnostic purposes, control of the course and evaluation of the results of therapy].
Prokopczyk J; Wańkowicz B; Wenzel E
Pediatr Pol; 1981 Aug; 56(8):883-8. PubMed ID: 7301482
[No Abstract] [Full Text] [Related]
18. Outcome of infants with neuroblastoma detected by mass screening and surgically treated in Shiga Prefecture, Japan: what is the role of surgery?
Hase T; Ohta S; Tani T; Mizukuro T; Mekata E; Naitoh H; Shimadera S; Fujino S; Taga T
Pediatr Surg Int; 2002 Sep; 18(5-6):289-94. PubMed ID: 12415341
[TBL] [Abstract][Full Text] [Related]
19. The role of bone marrow evaluation in the staging of patients with otherwise localized, low-risk neuroblastoma.
Russell HV; Golding LA; Suell MN; Nuchtern JG; Strother DR
Pediatr Blood Cancer; 2005 Dec; 45(7):916-9. PubMed ID: 16078212
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for scoliosis in children with neuroblastoma.
Paulino AC; Fowler BZ
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):865-9. PubMed ID: 15708267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
